Aktiesnakken — Oktober 2010
-
der er vist nogen, der ikke vil over 70
-
gen blev shortet ved udsigt til emission, det begyndte at køre i markedet allerede i kurs 200. Derfor shorte genmab
-
den i 70 er bare for at se om nogen vil spille bold....
-
det var jo en helt rigtigt short...jeg forstår bare ikke de ikke har afviklet dem alle sammen...efter aftalen med GSK
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind